Amneal Pharmaceuticals, Metsera Strike Deal to Co-Develop Medicines for Obesity, Metabolic Diseases

Partnership is expected to leverage Amneal’s global manufacturing and product development experience and Metsera’s portfolio of ultra-long acting injectables and oral nutrient-stimulated hormone analogs.